Prognostic role of baseline <sup>18</sup> F-FDG pet/CT in squamous cell carcinoma of the paranasal sinuses.

Dondi, Francesco; Pasinetti, Nadia; Guerini, Andrea; Piazza, Cesare; Mattavelli, Davide; Bossi, Paolo; Berruti, Alfredo; Ravanelli, Marco et al. · Head Neck · 2022

retrospective_cohort · Level III

Where this comes from

Abstract

To retrospectively investigate the prognostic role of baseline <sup>18</sup> F-FDG PET/CT in squamous cell carcinoma (SCC) of the paranasal sinuses. Clinical features and PET/CT semiquantitative parameters of 49 patients were collected. Anova and Kruskall-Wallis tests were used to assess the relationship between these parameters. Kaplan-Meier, univariate, and multivariate analysis were performed to search for independent prognostic factors for progression free (PFS) and overall survival (OS). Mean PFS was 29.95 months (SD 29.36) with relapse/progression of disease occurring in 18 patients; mean OS was 33.40 (SD 27.78) months with death occurring in 15 patients. Presence of nodal metastasis (14 subjects) was correlated with standardize uptake value (SUV) max, SUVmean, SUV/blood-pool ratio, SUV/liver ratio, metabolic tumor volume, and total lesion glycolysis. SUVmax, SUVmean, and presence of nodal metastasis resulted as independent prognostic factors for OS. <sup>18</sup> F-FDG PET/CT semiquantitative parameters confirmed their prognostic role for SCC of paranasal sinuses.

Medical subject headings